Aspirin decreases the risk of depression in older men with high plasma homocysteine
about
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illnessInflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.Mind and body: how the health of the body impacts on neuropsychiatry.Aspirin promotes oligodendrocyte precursor cell proliferation and differentiation after white matter lesion.Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention.Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies.The renin-angiotensin system: a possible new target for depression.Beneficial effect of aspirin against interferon-α-2b-induced depressive behavior in Sprague Dawley rats.Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.Immunoinflammatory Therapies in Psychiatry: Current Evidence Base.Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.Can body temperature dysregulation explain the co-occurrence between overweight/obesity, sleep impairment, late-night eating, and a sedentary lifestyle?Role of Aspirin and Dexamethasone against Experimentally Induced Depression in Rats.The effects of combined sertraline and aspirin therapy on depression severity among patients with major depressive disorder: A randomized clinical trial.Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.
P2860
Q34626598-D3E57F92-2CC2-4F01-8341-7ECA1D4088B0Q36023793-71EBED5E-50CA-4AC0-8B76-B6B75EC34A78Q37399776-4398A242-7EE8-45CA-857E-DBCD93DAA68EQ37517131-6D211854-3B9A-433C-B9D4-C60821FADE5EQ37705451-2DFD4638-FE47-45B2-BB42-99E9E66CB265Q38425127-01B54A55-94E8-4989-8790-813D92F2CDB1Q38651269-C07F6B8A-6F05-4816-A0E1-0EC425304F00Q39453966-170774EC-3477-4E3D-89E0-EDE63F056CCFQ40156599-763EA625-9E5A-4574-840E-2B5C25ED557BQ47137430-D37E33B1-A3B4-41DB-808B-F19811992C54Q47291324-086E5917-F78B-4C42-99E4-054CB31F2135Q47648526-5E3C2B49-06C1-4978-B338-7238FA089E25Q47683361-8C3D423A-ABEB-4BBE-AF5E-A641D6EB3CF2Q48069072-9B9B40D7-1D96-4FA5-BFEE-74E129CB41F4Q50061128-51767DD5-71DC-4DA3-B630-65E9C9641200Q50175494-8B060FC7-EBA1-40AF-8A46-E7F5CB31DC63
P2860
Aspirin decreases the risk of depression in older men with high plasma homocysteine
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@ast
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@en
type
label
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@ast
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@en
prefLabel
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@ast
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@en
P2093
P2860
P356
P1476
Aspirin decreases the risk of depression in older men with high plasma homocysteine
@en
P2093
P2860
P2888
P356
10.1038/TP.2012.79
P577
2012-08-14T00:00:00Z